Sotera Health Co balance sheet
At the end of fiscal 2025, Sotera Health Co had total assets of $3.26bn, total liabilities of $2.66bn and shareholders' equity of $606m. It held $345m in cash against $2.17bn of debt: net debt of $1.82bn.
Balance sheet
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 63 | 102 | 107 | 395 | 296 | 277 | 345 | 357 |
| Receivables | — | 92 | 108 | 118 | 148 | 140 | 139 | 151 |
| Inventory | — | 34 | 54 | 37 | 48 | 49 | 54 | 56 |
| Total current assets | — | 315 | 346 | 645 | 557 | 526 | 613 | 646 |
| Goodwill | 1,036 | 1,116 | 1,120 | 1,102 | 1,111 | 1,081 | 1,103 | 1,091 |
| Total assets | — | 2,761 | 2,790 | 3,118 | 3,130 | 3,072 | 3,263 | 3,307 |
| Accounts payable | — | 52 | 73 | 74 | 71 | 55 | 78 | 101 |
| Deferred revenue (current) | — | 6 | 9 | 12 | 13 | 15 | 18 | 14 |
| Total current liabilities | — | 141 | 161 | 792 | 231 | 191 | 250 | 231 |
| Short-term debt | — | 0 | 0 | 197 | 5 | 15 | 14 | 14 |
| Long-term debt | — | 1,825 | 1,744 | 1,747 | 2,224 | 2,208 | 2,127 | 2,126 |
| Total debt | 0 | 1,864 | 1,764 | 1,964 | 2,261 | 2,256 | 2,169 | 2,166 |
| Total liabilities | — | 2,307 | 2,203 | 2,767 | 2,687 | 2,667 | 2,657 | 2,641 |
| Shareholders' equity | −641 | 452 | 586 | 350 | 444 | 405 | 606 | 666 |
| Net debt (negative = net cash) | −63 | 1,761 | 1,657 | 1,568 | 1,964 | 1,978 | 1,825 | 1,809 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 130 | 140 | 128 | 137 | 142 | 139 | 137 | 151 |
| Inventory | 54 | 49 | 61 | 60 | 50 | 54 | 57 | 56 |
| Total current assets | 564 | 526 | 555 | 608 | 578 | 613 | 586 | 646 |
| Goodwill | 1,105 | 1,081 | 1,084 | 1,105 | 1,099 | 1,103 | 1,098 | 1,091 |
| Total assets | 3,149 | 3,072 | 3,098 | 3,217 | 3,186 | 3,263 | 3,236 | 3,307 |
| Accounts payable | 71 | 55 | 70 | 64 | 61 | 78 | 77 | 101 |
| Deferred revenue (current) | 11 | 15 | 14 | 12 | 14 | 18 | 14 | 14 |
| Total current liabilities | 196 | 191 | 226 | 246 | 242 | 250 | 208 | 231 |
| Short-term debt | 15 | 15 | 15 | 15 | 14 | 14 | 14 | 14 |
| Long-term debt | 2,211 | 2,208 | 2,205 | 2,203 | 2,129 | 2,127 | 2,124 | 2,126 |
| Total debt | 2,226 | 2,223 | 2,220 | 2,217 | 2,143 | 2,141 | 2,138 | 2,139 |
| Total liabilities | 2,679 | 2,667 | 2,683 | 2,705 | 2,636 | 2,657 | 2,613 | 2,641 |
| Shareholders' equity | 470 | 405 | 414 | 511 | 550 | 606 | 623 | 666 |
Compare with peers
- Bio-Techne balance sheet
- Repligen Corp balance sheet
- Neogenomics Inc balance sheet
- Qiagen N.V. balance sheet
- 10x Genomics, Inc. balance sheet
Head to head: SHC vs TECHRGEN vs SHCNEO vs SHC
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies